Population Pharmacokinetic Modeling of Flurbiprofen, the Active Metabolite of Flurbiprofen Axetil, in Chinese Patients with Postoperative Pain [Corrigendum]
Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. J Pain Res. 2018;11:3061– 3070.
Correction for “Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain” Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. Journal of Pain Research. 2018;11:3061– 3070.
The above article published in the Journal of Pain Research was under investigation for allegedly reporting results from an unrelated study using an unrelated clinical trial registration (CTR) number. We previously published an Expression of Concern to highlight this to readers while we completed our investigation:
Zhang J, Zhang H, Zhao L, Gu J, Feng Y, An H. Journal of Pain Research. 2019;12:2799. https://doi.org/10.2147/JPR. S231531.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]